Filing Flows › Nexgel (NXGL) › Q1 2026 › vs Q1 2025
Nexgel (NXGL) Q1 2026 vs Q1 2025 (year over year)
Nexgel's revenue fell $156K (-6%) from $2.8M in Q1 2025 to $2.6M in Q1 2026.
Nexgel, Q1 2026: revenue $2.6M (-6% year over year), operating margin -36.2%, net loss $871K, operating cash flow −$504K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $2.6M | $2.8M | −$156K | -6% |
| Other income, net | $87K | $99K | −$12K | -12% |
| Net loss | $871K | $678K | $193K | +28% |
| Costs & expenses | $3.6M | $3.6M | $25K | +0.7% |
| Operating costs | $3.6M | $3.6M | $25K | +0.7% |
| Cost of revenue | $1.6M | $1.6M | −$29K | -2% |
| Operating expenses | $2.0M | $2.0M | $54K | +3% |
| Operating cash sources | $871K | $678K | $193K | +28% |
| Depreciation & amortization | $99K | $114K | −$15K | -13% |
| Share-based compensation | $143K | $166K | −$23K | -14% |
| Working capital & other | $125K | −$2K | $127K | — |
| Cash used in operations | $504K | $400K | $104K | +26% |
| Net loss absorbed | $871K | $678K | $193K | +28% |
Questions
How much did Nexgel's revenue grow year over year in Q1 2026?
Nexgel's revenue fell $156K (-6%) from $2.8M in Q1 2025 to $2.6M in Q1 2026.